---
layout: post
title: "港股生物医药B类股全线下跌"
date: 2022-01-25 14:20:44 +0800
categories: gelonghui
tags: 格隆汇新闻
---
<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.01167" data-code="01167|116|5" data-code2="01167|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquotepic.eastmoney.com/GetPic.aspx?nid=116.01167&imageType=r&token=28dfeb41d35cc81d84b4664d7c23c49f" alt="R图 01167_0" data-code="R 01167|116|5" data-code2="R 01167|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" border="0" /></a></p><!-- EM_StockImg_End --><p>加科思和德琪医药跌超10%，歌礼制药、堃博医疗跌近10%，永泰生物、沛嘉医疗跌超8%，心玮医疗、归创通桥和康宁杰瑞跌超7%，药明巨诺跌超6%，诺辉健康、欧康维视和科济药业跌超5%。 <br /></p><p class="em_media">（文章来源：格隆汇）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202201252260814091>

[返回格隆汇新闻](//finews.withounder.com/category/gelonghui.html)｜[返回首页](//finews.withounder.com/)